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Gastrointestinal Stromal Tumor Associated with Hypertrophic Osteopathy in a Dog
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e Silva Pereira3, Danilo Gouveia Wasques4, Paula Elisa Brandão Guedes5 & Renata Santiago Alberto Carlos6
ABSTRACT
Background: Gastrointestinal stromal tumor (GIST) is a malignant mesenchymal neoplasm rarely described in the vet-
erinary routine. The aim of this study was to report a case of GIST accompanied by a periosteal reaction, suggestive of 
hypertrophic osteopathy, in a dog.
Case: An 11-year-old male dog had a history of progressive weight loss, difficulty in locomotion, and dyspnea. During clini-
cal care, increased bone volume was observed. Blood samples were collected for a complete blood count and biochemical 
analysis. The dog also underwent thoracic radiography and abdominal ultrasonography. The test results revealed anemia, 
leukocytosis, hypocalcemia, hypoalbuminemia, and hypocholesterolemia. The radiographic images of the limbs showed 
a generalized periosteal reaction, and thoracic radiography indicated changes compatible with mild chronic lung disease. 
Ultrasonographic findings indicated a neoformation in the intestinal loop of the right mesogastric region and increased 
volume in the left testicle, both of which were indicative of neoplasia. Therefore, the dog was referred for surgery, wherein 
the intestinal mass and both testes were removed; the intestinal mass and left testicle were subjected to histopathological 
diagnosis. The results of the biopsies confirmed that the testicular neoplasm was a seminoma, whereas the intestinal nodule 
was compatible with GIST, and immunohistochemical analysis was necessary to confirm the diagnosis. On the basis of 
positive labeling for the antibodies vimentin, desmin, S100, and c-kit, the diagnosis of GIST was confirmed. Therefore, 
the animal underwent metronomic chemotherapy with 12 mg/m2 cyclophosphamide every 24 h for 3 months, and there-
after every 48 h for 6 months. Moreover, the dog was periodically monitored via imaging (radiography of the anterior 
and posterior limbs, abdominal ultrasonography, and computed tomography). A few months after the surgical resection 
of the intestinal nodule, radiography revealed that the periosteal reactions had disappeared, but ultrasonography revealed 
nonspecific alterations of mild thickening and enlargement of the intestinal loops. Computed tomography revealed two 
nodular areas of soft-tissue attenuation in the right mesogastric region. Although the possibility of tumor recurrence was 
raised, the animal’s owner chose only to perform palliative treatment. After 4 months, ultrasonography revealed a neofor-
mation in the right mesogastric region. On July 29, 2018 the animal had a worsening of its clinical condiction, with tumor 
recurrence by ultrasound exam. The owners didn´t accept returning to the oncologist and made an option for a conservative 
treatment with tramadol (3 mg/kg/TID), dipirone (25 mg/kg/TID), and vitaminic supplement based on docosahexaenoic 
acid plus eicosapentaenoic acid (30 mg/kg, once daily). On August, 28, 2018 he was euthanized. The dog’s postsurgical 
survival time was 15 months.
Discussion: The dog described in the present report was large and elderly, both of which are predisposing factors for GIST 
development. Although non-specific, progressive weight loss may be associated with intestinal neoplasia, owing to the 
impairment of digestion and nutrient absorption, because a part of the duodenal mucosa was compromised by neoplasia. 
The difficulty in locomotion, which did not respond to treatment, was attributed to the periosteal reaction confirmed by 
radiographic exam. This, in turn, was associated with hypertrophic osteopathy secondary to neoplasia, because the condi-
tion regressed after the removal of the intestinal nodule. The histopathological findings related to intestinal neoplasia were 
suggestive of GIST; positive immunoblotting for c-kit, vimentin, S100, and desmin confirmed the diagnosis. Although the 
veterinarian alerted the owner to the suspicion of recurrence and suggested continuing treatment, the owner chose not to.
Keywords: Canis familiaris, hypertrophic osteopathy, immunohistochemical diagnosis, intestinal sarcoma, tomography.
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INTRODUCTION
Neoplasms of the gastrointestinal tract are poor-
ly reported in the veterinary routine, and account for only 
about 1% of malignancies described in dogs. Among 
these, smooth muscle mesenchymal neoplasms are the 
second most diagnosed type [1], with gastrointestinal 
stromal tumor (GIST) being the most common [8,15].
GIST is derived from the interstitial cells of 
Cajal, present in the gastrointestinal wall, and has 
histological characteristics of both smooth muscle 
tissue and neural tissue [1,7,9,14,16]. Its clinical signs 
are nonspecific and include weight loss, anorexia, 
and vomiting [2,14]. The diagnosis is based on the 
association of clinical signs and imaging techniques, 
such as endoscopy, ultrasonography, and computed 
tomography, which allow the visualization of neo-
plastic formation; however, confirmation requires 
histopathological and immunohistochemical analyses 
of the tumor [2,16,18]. The treatment of choice is the 
surgical removal of the mass with safe margins, but 
the efficacy of chemotherapy in dogs with this type of 
tumor remains unknown [1,2].
Some neoplasms may be accompanied by 
hypertrophic osteopathy, characterized by periosteal 
reaction, that occurs because of increased periosteal 
activity. It has been reported to accompany lung dise-
ases in dogs, as well as secondary to thyroid carcinoma 
and renal sarcoma [7]. Nevertheless, bone alteration 
in cases of gastrointestinal tumors has not yet been 
reported. The aim of this study was to report a case of 
GIST in a dog with hypertrophic osteopathy.
CASE
An 11-year-old male Labrador dog, weighing 
28.2 kg, with a history of difficulty in locomotion and 
weight loss for approximately 3 months, in addition 
to dyspnea, presented to a private clinic in Petrópolis 
- RJ, on May 16, 2017. The owner reported previous 
use of chondroitin and glucosamine at a dose of 100 
mg/kg (Condroton 1000)1 6 months ago, but with no 
improvement in locomotion difficulty. A clinical ex-
amination revealed an increase in the volume of bones 
(Figure 1), mainly the radius/ulna, metacarpals, right 
and left metatarsals, as well as abdominal sensitivity. 
On auscultation, a holosystolic murmur grade II was 
identified in the mitral focus.
The following complementary tests were per-
formed: complete blood count, biochemical analysis of 
glucose, creatinine, phosphorus, calcium, prothrombin 
time, albumin, globulin, alanine aminotransferase, al-
kaline phosphatase, gamma glutamyl transferase, total 
bilirubin, and cholesterol (on May 16, 2017), as well as 
chest radiography and abdominal ultrasonography (on 
May 18, 2017). The results of the hematological tests 
revealed anemia (hematocrit of 21.8%), leukocytosis 
(24.4 K/μL), hypocalcemia (7.6 mg/dL), hypoalbumin-
emia (1.8 g/dL), and hypocholesterolemia (105 mg/dL), 
according to the reference values described by Kaneko 
et al. [12]. Radiographic images of the right and left 
limbs showed generalized periosteal reaction in distal 
diaphysis and metaphysis of humerus, and in radius, 
ulna, fibula, metacarpal and metatarsals bones (Figure 
2A). Moreover, the images revealed incongruence of the 
humeral-radio-ulnar joints and loss of anatomical defini-
tion of the anomalous processes of the ulnar joints, pre-
senting osteophytic formations in the medial and lateral 
umbilical condyles, radial heads, ulnar medial coronoid 
processes, and medial humeral epicondyles, suggesting 
a degenerative joint disease like osteoarthrosis. The bone 
alterations were suggestive of hypertrophic osteopathy. 
In addition, soft-tissue volume increase, consistent 
with secondary inflammation, was observed. Thoracic 
radiographic exam indicated changes compatible with 
mild chronic lung disease. Ultrasonographic findings 
indicated a neoformation in the right mesogastric re-
Figure 1. An 11-year-old male Labrador dog. Note the increased volume 
in the left radius/ulna bone (red arrow). 
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gion, measuring approximately 10.04 × 6.84 cm; with 
thick hypoechoic walls that were slightly heterogeneous 
and measuring 2.38 cm; with some cystic structures 
measuring approximately 2.0 × 1.0 cm; and presenting 
vascularity on Doppler imaging; these findings were 
compatible with neoplasia (Figure 3). In addition, the 
left testicle presented a volume increase, globose aspect, 
heterogeneous surface, loss of definition of the medi-
astinal line, and discrete vascularization on Doppler 
imaging, thereby indicating neoplasia.
Thus, the animal was referred for exploratory 
laparotomy, performed on May 19, 2017, during which 
the intestinal tumor was resected (Figure 4), together 
with intestinal anastomosis and orchiectomy. Samples 
of the nodule located in the duodenum and left testicle 
were subjected to histopathological analysis.
Microscopic evaluation of the intestinal nodule 
revealed spindle-shaped neoplastic cells in bundles, 
Figure 2. A- Radiographic image of the left tarsals and metatarsals of a 
dog before surgery for the removal of an intestinal nodule. Note the peri-
osteal reaction (red arrow). B- Radiographic image of the left tarsals and 
metatarsals of a dog after surgery for the removal of an intestinal nodule. 
Note the absence of the periosteal reaction.
Figure 3. A- Ultrasonographic findings indicating an intestinal loop neoformation, measuring approximately 10.04 × 6.84 cm; with thick hypoechoic 
walls, slightly heterogeneous and measuring 2.38 cm; and with some cystic structures measuring approximately 2.0 × 1.0 cm; these findings are com-
patible with neoplasia. B- Ultrasonographic findings of the same mass indicated in A, presenting vascularity on Doppler imaging; this finding is also 
compatible with neoplasia.
Figure 4. Removal of the intestinal tumor, measuring approximately 10 
cm, located in the duodenum (red arrow). 
rarely with palisade formation and mild to moderate 
stromal myxoid matrix deposition. The neoplastic 
cells showed marked anisokaryosis, with prominent 
and multiple nucleoli of varying sizes and coarse 
aggregation of chromatin as well as a high mitotic 
index, with some atypical figures (Figure 5 A & B). 
The histopathological diagnosis was that it was a 
poorly differentiated neoplasm suggestive of GIST, 
but immunohistochemical evaluation was necessary 
to confirm the diagnosis. The immunohistochemical 
profile of the tumor cells was assessed using immu-
nolabelling with c-kit, vimentin, S100, desmin, 1A4, 
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Figure 5. A- Gastrointestinal stromal tumor in a dog’s duodenum. Note the spindle-shaped neoplastic cells arranged in bundles (red arrow), rarely with 
palisade formation and discrete to moderate stromal myxoid matrix deposition [HE; 10x]. B- Gastrointestinal stromal tumor in a dog’s duodenum. Note 
the neoplastic cells with marked anisokaryosis (red arrow), prominent and multiple nucleoli of varying sizes, and coarse aggregation of chromatin. 
Frequent mitosis (blue arrow) [HE; 40x].
Figure 6.  Immunohistochemical features of the nodule suggestive of gastrointestinal stromal tumor in a dog. A- Note the positive c-kit immunolabelling 
(arrows) [20x]. B- Notice the positive immunoblotting for vimentin (arrows) [20x].
HHF35, and AE1/AE3. The reactions were positive for 
the first four antibodies (Figure 6A & B); therefore, 
in association with the histopathological findings, the 
diagnosis was confirmed as GIST. The left testicle 
showed a high cell density, composed of round germ 
cells arranged in mantles in the middle of a discrete 
fibrovascular stroma. Neoplastic cells had rounded, 
vesiculous nuclei with prominent nucleoli and mode-
rate to marked anisokaryosis, with a moderate mitotic 
index. The diagnosis was seminoma.
On the basis of the histopathological and im-
munohistochemical test results of the gastrointestinal 
tumor, the animal was referred for metronomic chemo-
therapy, which started on June 23, 2017. Chemotherapy 
involved the administration of 12 mg/m2 cyclophos-
phamide2 every 24 h. This chemotherapy schedule was 
followed for 3 months; thereafter, it was administered 
every 48 hours, and was completed in March 2018.
In the first week of chemotherapy, the animal 
was again clinically evaluated to perform the clinical 
review, which showed that the dog presented no clini-
cal alterations. New radiographic and ultrasonographic 
exams were requested for control. After 38 days of 
surgical resection, the radiographic report revealed 
that the periosteal reactions had disappeared (Figure 
2B). Abdominal ultrasonography showed no signifi-
cant changes.
To monitor the evolution of the case, another 
abdominal ultrasonography was performed on August 
8, 2017, which indicated that the duodenum presented 
a distension, measuring between 1.92 and 2.66 cm in 
diameter, with irregular walls, measuring between 
0.55 and 0.98 cm; these findings were compatible with 
recurrent neoplasia. On the basis of these results, to 
monitor the evolution of this possible recurrence, the 
animal was submitted to new abdominal ultrasonogra-
phy on October 26, 2017. The ultrasonographic findin-
gs indicated a segment of the duodenum presenting a 
decrease in the differentiation of the layers, measuring 
approximately 1.49 cm in diameter, suggestive of post-
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surgical fibrosis; however, the possibility of recurrence 
of the previously removed neoplasia was not ruled out. 
Thus, periodic monitoring of the animal, through con-
sultations with the veterinary doctor and completion 
of complementary tests, was suggested to the owner.
On March 5, 2018, the animal was reassessed 
and submitted to abdominal computed tomography 
(Figure 7). This exam revealed two nodular areas of 
soft-tissue attenuation with defined limits in the right 
mesogastric region of the mesentery. The first of these 
was located near the visceral wall of the duodenum, 
with a separation plane, measuring about 0.90 cm in 
diameter. The other was located ventrocaudal to the 
right branch of the pancreas, without contact between 
the structures, measuring about 1.0 cm in diameter. 
These findings were interpreted by the veterinarian 
as suggestive of new mesentery and lymph node 
enlargement. Since these findings were considered 
nonspecific, the animal was periodically monitored 
by the veterinarian.
the quality of life of the animal. Thus, tramadol3 (3 mg/
kg/TID), dipirone4 (25 mg/kg/TID), and vitaminic sup-
plement based on docosahexaenoic acid plus eicosapen-
taenoic acid5 (30 mg/kg, once daily) were prescribed. 
Besides the prescription, the clinical condition went 
badly and the dog was euthanized oh August 29, 2018. 
The dog’s postsurgical survival time was 15 months, 
without any recurrence of hypertrophic osteopathy.
DISCUSSION
The male dog described in the present report was 
large and elderly, both of which are predisposing factors 
reported to lead to the development of GIST [2,8,9,14]. 
In addition, Labradors have been reported to be more 
affected by gastric neoplasias than are other breeds, but 
this association still lacks justification [2,14].
Progressive weight loss in an animal is a chan-
ge, albeit a non-specific sign, that may be associated 
with GIST [2,8,14]. Weight loss is probably associated 
with impaired digestion and absorption of nutrients 
by the animal, since a part of the duodenal mucosa 
is compromised by neoplasia. In addition, it may be 
associated with cancer cachexia.
Another clinical sign presented by the animal 
was difficulty in locomotion that was not responsive 
to palliative treatment and was attributed to the perios-
teal reaction, which led to pain and was confirmed by 
radiographic exam. Although hypertrophic osteopathy 
has not yet been reported secondary to gastrointestinal 
neoplasms, it has been associated with other tumors 
in dogs [7]. In the veterinary literature, there are some 
reports of neoplastic upper gastrointestinal tract proces-
ses associated with hypertrophic osteopathy, such as 
esophageal embryonal rhabdomyosarcoma and esopha-
geal sarcomas secondary to Spirocerca lupi infection 
[8]. However, no studies have described the association 
of neoplastic processes in the lower gastrointestinal 
tract with paraneoplastic syndrome in dogs. The as-
sociation between GIST and hypertrophic osteopathy 
was based on the regression of bone alteration after the 
surgical removal of the intestinal mass. In addition, the 
fact that the periosteal reaction manifested bilaterally 
indicated that this would be secondary to a systemic 
process [19], as in the case presented, which helped 
rule out the possibility of a bone metastasis of GIST.
The periosteal reaction occurs because of a re-
action of the bone cortex, characterized by an increase 
in the periosteum; however, its pathogenesis associated 
Figure 7. Abdominal computed tomography of a dog. A nodule measuring 
about 1.0 cm in diameter (red arrow), with defined and regular limits and 
homogeneous softening of parts is located ventrocaudally at the end of the 
right branch of the pancreas, through the mesentery.
On July 23, 2018, after performing new tests 
on the dog, ultrasonography revealed a heterogeneous 
formation in the right medial portion of the mesogastric 
region, measuring 5.47 × 3.36 cm and 4.87 × 4.15 cm, 
and presenting some cavitary areas. Discrete Doppler 
vascularization was observed, and this was more evi-
dent in the periphery of the formation. The sonographic 
image suggested a neoplastic process, compatible with 
relapse or metastatic focus of the previous formation. 
Thus, histopathological exam of this formation was 
recommended for a better interpretation of the findings.
The owner was informed about the suspicion 
of relapse; however, he chose not to perform any other 
procedure, and only approved of treatment to maintain 
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with neoplasias remains unknown. According to the 
literature, this presentation has several alterations; in 
the present case, the radiographic characteristics of 
the lesion were suggestive of the periosteal palisade 
reaction. Nevertheless, because of the lack of reports 
in veterinary medicine about this association with 
GIST, it remains unclear if this pattern of periosteal 
reaction observed in the present dog is characteristic 
of this tumor [19]. The chest radiographic exam results 
also showed no relationship between the pulmonary 
alteration and neoplasia.
The present case is atypical because it is a 
possible case of hypertrophic paraneoplastic osteo-
pathy in the absence of neoplastic lesions (primary 
or metastatic) in the thoracic cavity. In recent retros-
pective studies, the presence of neoplastic formations 
in the thoracic cavity (whether in the lung tissue or 
adjacent structures) has been a consistent finding 
in cases of hypertrophic paraneoplastic osteopathy 
[22,23]. However, the literature contains descriptions 
of some isolated cases of hypertrophic paraneoplastic 
osteopathy associated with extrathoracic tumors (in 
the absence of thoracic metastases), including hepato-
cellular carcinoma in a dog, ovarian granular cell tumor 
in a mare, and transitional renal pelvic carcinoma in 
a dog, among others [10,17,20]. The justification for 
the occurrence of the syndrome in these extrathoracic 
cases is unclear, but it is possible that the osteopathy 
occurs because of the stimulation of the extrathoracic 
portions of the vagus nerve.
Among the hematological changes observed in 
this dog, anemia and leukocytosis were also reported 
by Leandro & Sá [14] in dogs with GIST evaluated in 
their research. According to these authors, anemia may 
be secondary to blood loss from the intestinal mucosal 
injury caused by the mass as the disease progresses. 
Leukocytosis can be justified by bacterial infection se-
condary to ulceration of the intestinal mucosa as well as 
necrosis of neoplastic cells. In addition, inflammatory 
processes are usually accompanied by an increase in 
the number of circulating leukocytes.
Although biochemical changes were also 
found in the blood of this dog, these were considered 
nonspecific and, according to the literature, unrelated 
to GIST [14]. However, it is worth mentioning that 
hypoalbuminemia may be related to gastrointestinal 
protein loss owing to neoplasia involvement, and it 
is a finding that has also been described in cases of 
hypertrophic paraneoplastic osteopathy, as observed in 
11 of 19 animals in a previous study [23]. Nevertheless, 
the mechanism of hypoalbuminemia in the context of 
hypertrophic osteopathy remains unclear.
In the present case, ultrasonographic findings 
led to the suspicion of intestinal neoplasia once a vascu-
larized mass was found in the duodenum; this prompted 
the veterinarian to opt for exploratory laparotomy for 
resection of the tumor. According to the literature, 
ultrasonography can aid the imaging diagnosis of 
gastrointestinal tumors [2], and in the present case, it 
was decisive to the referral of the animal to surgery. 
However, the most sensitive diagnostic technique for 
suspected cases of gastrointestinal neoplasms is com-
puted tomography. This exam provides a presurgical 
evaluation with respect to tumor extension and inva-
sion, thus aiding in surgical planning and the identifica-
tion of possible metastases [10,18]. In the present case, 
computed tomography was only performed after the 
removal of the nodule, as an auxiliary tool to monitor 
the progression of the disease, a condition for which 
this test is also indicated [18]. Computed tomography 
was not initially performed for diagnosis owing to its 
high cost compared to that of ultrasonography; mo-
reover, a computed tomography device for animals 
was as yet unavailable in the city at the time the dog 
first presented for treatment. However, considering 
the higher sensitivity of computed tomography for the 
diagnosis of gastrointestinal neoplasms, the dog was 
submitted to these exam during follow-up, when the 
device became available in the region.
In addition, because of the suspicion of testi-
cular neoplasia, orchiectomy was performed, which 
enabled the performance of the biopsy and helped 
arrive at the seminoma diagnosis. Interestingly, the 
testicular neoplasm was an incidental finding, and 
there was no relationship between this and the other 
alterations reported in the animal.
The veterinary literature contains rare refe-
rences to genital tract neoplasias in association with 
hypertrophic osteopathy, including a case of malignant 
Sertoli cell tumor in a dog, dysgerminoma in a mare, 
and ovarian tumor of granulosa cells in a mare [3,17]. 
With the exception of the granulosa cell tumor, the 
other two cases presented metastatic disease in the 
thoracic cavity (in the lung and mediastinal lymph no-
des), and the trigger factor of hypertrophic osteopathy 
in these cases was probably the metastatic lesions in 
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the thoracic cavity, and not the primary formations. In 
the present case, although it is not possible to comple-
tely rule out the causal association of seminoma with 
hypertrophic osteopathy, this seems less likely because 
of the absence of evidence of metastasis in the thoracic 
cavity. Considering the proposed pathophysiology of 
hypertrophic osteopathy, it would be unreasonable to 
suggest that neoplasia located in a scrotal pocket could 
interfere with neurovagal stimulation.
The option for surgical resection of the in-
testinal mass was supported by the literature, which 
indicates this as the treatment of choice for cases of 
gastrointestinal tumors [1,2], even though only few re-
ports have documented the treatment of GIST in dogs. 
In human medicine, patients with GISTs, after surgical 
resection, are usually submitted to adjuvant therapy 
with imatinib mesylate, a tyrosine kinase inhibitor. 
This drug interferes with the activity of tyrosine kinase 
(c-kit) receptors, which, as will be discussed later, are 
of utmost importance in the development of GIST [18]. 
This therapy has been reported in veterinary medicine 
in association with other forms of chemotherapy for 
mastocytoma, a neoplasm that also exhibits mutations 
in the c-kit receptor [13], but no reports have docu-
mented its use in cases of GIST in dogs. In the present 
case, chemotherapy with cyclophosphamide2 was the 
recommended complementary therapy for soft-tissue 
sarcoma [2], since the owner did not agree to submit 
the animal to treatment with imatinib mesylate.
The neoplasm in the present case was appro-
ximately 10 cm in diameter, which is in agreement 
with the size described in the literature. According 
to Leandro & Sá [14], GISTs are neoplasias that can 
reach diameters of up to 30 cm, thus compromising 
the mucous and muscular layers of the intestine. This 
reiterates the hypothesis that the dog’s weight loss 
was due to the reduction of the intestinal absorption 
surface. Although the size of gastric tumors has been 
related to their aggressiveness in human medicine, 
veterinary medicine still lacks studies on these neo-
plasms to confidently suggest such an association. In 
addition, the location of the mass corroborates with 
that reported in the veterinary routine, which indicates 
that the intestinal loops are the portion of the digestive 
system most affected by GIST in dogs, and that the 
duodenum is the second most described portion with 
this neoplasia [8,14,21].
The histopathological findings of the intestinal 
nodule were compatible with the literature description 
for GIST [8,9,14,16]. However, since soft-tissue sarco-
mas have high heterogeneity among the tumor cells that 
make up the tumor, immunohistochemical evaluation 
is often necessary to complete the diagnosis [2], as 
was used in the present report. The antibodies c-kit, 
vimentin, S100, and desmin used in the present case 
are the most commonly used in the veterinary routine 
to confirm cases suggestive of GIST [14,16]. Vimentin 
is a protein expressed by most mesenchymal cells; thus, 
immunopositivity to this antibody indicated the me-
senchymal origin of the tumor cells from the intestinal 
nodule. According to Leandro & Sá [14], all intestinal 
stromal tumors are positive for vimentin. In addition, 
the cellular labeling for desmin, a protein expressed by 
smooth muscle cells, was consistent with that reported 
in the literature, which indicates that GIST has histo-
logic features of smooth muscle tissue. In addition, 
S100 antibody labelling, which is characteristic of 
changes originating from the myenteric nerve plexus, 
corroborated with the literature, thereby indicating that 
this neoplasm also had histological features of neural 
tissue [1,7,9,14,16]. According to Frost et al. [8], more 
than 70% of GISTs may be positive for S100.
Regarding the immunostaining of c-kit, a 
transmembrane receptor tyrosine kinase, the positive 
result confirmed the diagnosis of GIST, since the in-
terstitial Cajal cells (which give rise to this neoplasia) 
express the c-kit receptor, which makes it sensitive to 
such a diagnosis. c-kit is important for the prolifera-
tion, adhesion, apoptosis, and differentiation of Cajal 
cells. In cases of granulomatous stromal tumors, the 
abnormal and exacerbated proliferation of Cajal cells is 
due to mutations that trigger tyrosine kinase receptors, 
triggered by the proto-oncogene KIT, and these muta-
tions are identified in more than 90% of GISTs [16]. 
Thus, by combining the immunostaining results for the 
above mentioned antibodies with the histopathological 
characteristics of the tumor, it was possible to confirm 
the origin of the neoplastic cells and, consequently, 
arrive at the diagnosis of intestinal neoplasia. It is worth 
mentioning that, more recently, the DOG1 antibody 
has been suggested as a more sensitive marker for the 
diagnosis of GIST (especially in c-kit-negative cases). 
DOG1 is a plasma membrane protein that is involved 
in the transport of chlorine [6].
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GIST should be differentiated from other me-
senchymal neoplasms, such as leiomyoma, leiomyo-
sarcoma, schwannoma, neurofibroma, and neuroendo-
crine tumors, that may exhibit histopathological simila-
rities to it, albeit with different immunohistochemical 
profiles [18,21]. More recently, an additional category 
of intestinal sarcomas has been proposed, classified 
as “non-GIST sarcoma and non-leiomyosarcoma,” 
which is negative for specific immunohistochemical 
markers of these neoplasms [11]. This information 
reinforces the importance of immunohistochemical 
profiling of suspected GIST neoplasias, as was done 
in the present case.
Data from the literature indicate that dogs 
with GIST submitted only to surgical treatment have 
an average survival time of 37.4 months [21]. There 
are no reports on the survival time of dogs with GIST 
submitted to postsurgical treatment with cyclophospha-
mide2. However, Araújo et al. [2] reported an average 
survival time of 7.5 months in dogs with soft-tissue 
sarcomas that received chemotherapy, as in the present 
study. The dog reported herein presented a 15-month 
survival period after surgical removal and received 
chemotherapy as adjuvant therapy, twice as long as that 
observed by Araújo et al. [2]. However, about 3 mon-
ths after the surgical removal of the intestinal nodule, 
areas compatible with possible recurrence were noted. 
Although the veterinarian alerted the owner about con-
tinuing treatment, the owner chose not to. Thus, it was 
not possible to infer if the follow-up ultrasonographic 
images were actually suggestive of tumor recurrence, 
since surgical resection and subsequent microscopic 
analysis of the sample would have been necessary for 
confirmation.
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